Blackstone is investing $2 billion in Alnylam Pharmaceuticals, giving the biotech firm the cash it needs to bring more drugs to market
Blackstone Group Inc. is investing $2 billion in Alnylam Pharmaceuticals Inc. through a combination of equity and debt, giving the biotech company the cash it needs to bring more of its products to market.
The biggest piece of the deal, which the companies expect to announce later Monday, consists of a $1 billion investment led by Blackstone Life Sciences to purchase up to 10% of the future total royalties of inclisiran, a drug to treat high cholesterol. The life-sciences unit will also invest up to $150 million in the development...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WSJ News Exclusive | Veterans Affairs Hospitals Will Give Masks Only to Some Employees, Memos ShowA shortage of face masks and N95 respirators amid the coronavirus pandemic has led the Department of Veterans Affairs to tell hospitals to decide which employees get masks and which don’t, according to internal memos reviewed by The Wall Street Journal.
Read more »
WSJ News Exclusive | U.S. Olympic Sports Groups Seek Government AidThe coronavirus pandemic has prompted sports bodies that usually generate much of their own revenue to seek help.
Read more »
WSJ News Exclusive | U.S. Medicare Agency Said to Seek Better Covid-19 Disclosures by Nursing HomesThe Centers for Medicare and Medicaid Services is expected to take action to make elder care facilities share more information about coronavirus cases with residents, staff and family members.
Read more »
WSJ News Exclusive | Amid Coronavirus Pandemic, China Bans Domestic Trade of Wild Animals, but Offers Tax Breaks for ExportsChina shut down domestic wild-animal traders on fears their goods sparked the coronavirus pandemic. Now officials are offering tax breaks to export products like edible reptiles, civet musk and rhino horn overseas.
Read more »